Introduction to Cagrilintide Bulk Powder
Cagrilintide is a synthetic peptide analogue of human amylin, engineered specifically for laboratory investigation of metabolic signaling and receptor pharmacology. Structurally derived from the native amylin sequence, this compound incorporates targeted amino acid substitutions and a lipidated side chain to confer extended stability under experimental conditions. Cagrilintide bulk powder is supplied as a lyophilized solid, intended exclusively for reconstitution and in vitro research use. It is not manufactured as a pharmaceutical ingredient nor approved for any diagnostic, therapeutic or in‑vivo human application. Researchers worldwide procure the bulk powder to study receptor binding kinetics, intracellular signaling cascades, and peptide stability profiles in controlled benchtop environments.
Contemporary laboratory programs utilize Cagrilintide bulk powder to characterize amylin receptor subtypes, compare species‑dependent binding affinities, and explore cross‑reactivity with related calcitonin family receptors. Because the peptide is offered in bulk quantities with documented lot‑specific purity data, it serves as a dependable reference material for analytical method development, including HPLC assay calibration and mass spectrometry tuning. The lyophilized format minimizes degradation during shipment and storage, enabling long‑term project planning without compromising biochemical integrity.
Chemical and Physical Properties
Cagrilintide consists of a 37‑amino‑acid chain patterned after human amylin, in which three proline substitutions (A25P, S28P, S29P) reduce the tendency for β‑sheet aggregation. A palmitic acid (C16) moiety is conjugated to the N‑terminal lysine via a γ‑glutamate spacer, a modification that promotes reversible albumin association and prolongs the peptide’s half‑life in buffered media. The molecular formula is approximately C₁₆₇H₂₅₅N₄₁O₅₇, and the monoisotopic molecular weight is close to 4,131 daltons (as free base), although the exact mass varies slightly depending on counter‑ion and hydration state.
The lyophilized powder presents as a white to off‑white, electrostatic, amorphous solid. For laboratory reconstitution, solubility data indicate that Cagrilintide dissolves readily in sterile water, dilute acetic acid (0.1% v/v), or dimethyl sulfoxide (DMSO) at concentrations commonly used for stock solutions (1–10 mg/mL). Researchers are advised to prepare aliquots in a sterile environment and avoid repeated freeze‑thaw cycles to preserve structural fidelity. The peptide’s isoelectric point, determined from the primary sequence, lies in the basic range, guiding selection of appropriate buffer systems for downstream assays.
Purity and Analytical Specifications
Each batch of Cagrilintide bulk powder undergoes rigorous analytical characterization before release. Purity is assessed by reversed‑phase high‑performance liquid chromatography (RP‑HPLC), with a typical acceptance criterion of >95% peak area. Residual solvents and counter‑ions are monitored according to ICH Q3C guidelines, and the trifluoroacetate content is quantified when the peptide is supplied as the TFA salt. Identity confirmation relies on two independent techniques:
- Mass spectrometry: Electrospray ionization (ESI‑MS) or matrix‑assisted laser desorption/ionization (MALDI‑TOF) verifies the molecular weight within ±0.5 Da of the theoretical value.
- Amino acid analysis (AAA): Acid hydrolysis followed by derivatization and chromatographic separation confirms the expected residue composition and quantifies the exact peptide content per mass of lyophilized powder.
Circular dichroism (CD) spectroscopy may optionally be employed to assess secondary structure in solution, and endotoxin levels are determined by Limulus amebocyte lysate (LAL) assay when the material is intended for cell‑based studies. Full documentation of these analyses is compiled in the batch‑specific Certificate of Analysis.
Storage and Stability
Lyophilized Cagrilintide bulk powder is stable for multiple years when stored at –20 °C in a desiccated, light‑protected container. The absence of moisture is critical to prevent hydrolysis of the labile asparagine and glutamine residues; therefore, vials should be sealed under inert gas and allowed to reach room temperature before opening to avoid condensation. Under these conditions, real‑time stability studies from peptide manufacturers demonstrate negligible degradation or aggregation over 36 months.
Once reconstituted, the peptide solution should be used immediately for optimal activity. If short‑term storage is unavoidable, aliquots can be kept at –20 °C for up to four weeks, although a loss of signal in receptor binding assays may begin after two weeks. Avoid storage at 4 °C beyond a few hours, as liquid water greatly accelerates deamidation and aggregation. Laboratories are encouraged to validate stability under their specific buffer conditions and freeze‑thaw protocols to ensure reproducibility.
Research Applications of Cagrilintide
The primary value of Cagrilintide bulk powder lies in its utility as a molecular tool for dissecting amylin receptor biology. Academic and industrial laboratories employ the peptide in a range of in vitro models—from transfected cell lines to primary tissue cultures—to examine binding modalities, post‑receptor signaling, and metabolic endpoints without the confounding factors present in whole‑organism studies. Its long‑acting profile, conferred by the lipid anchor, makes it particularly suitable for prolonged incubation experiments where receptor desensitization and trafficking are of interest.
Key investigative domains include competitive displacement assays to rank‑order amylin analogues, co‑administration experiments with GLP‑1 receptor agonists to probe crosstalk, and cryo‑electron microscopy studies of the receptor‑peptide complex. Investigators also use the bulk powder to prepare stock solutions for surface plasmon resonance (SPR) chips, enabling kinetic analysis of ligand‑receptor interactions in real time.
Receptor Binding Studies
Cagrilintide displays high‑affinity interaction with amylin receptors (AMY₁ and AMY₃ subtypes), which are heterodimers of the calcitonin receptor and receptor activity‑modifying proteins (RAMPs). Radioligand competition assays using ¹²⁵I‑amylin on CHO‑K1 or HEK293 cells stably expressing these receptor complexes are standard approaches to characterize binding parameters (Kd, Bmax, IC₅₀). Such experiments often reveal species‑specific pharmacology; for instance, binding affinity to rodent amylin receptors may differ from that observed with primate receptor orthologs, information crucial for interpreting data across model systems.
Researchers also utilize Cagrilintide in functional assays that measure receptor activation via β‑arrestin recruitment (e.g., PRESTO‑Tango or PathHunter platforms). These data help map the signaling bias of the peptide—whether it preferentially engages G‑protein or β‑arrestin pathways—and how structural modifications at the lipid anchor influence functional selectivity.
Metabolic Pathway Analysis
In cultured hepatocytes, pancreatic β‑cell lines, or hypothalamic neuronal models, Cagrilintide bulk powder is used to interrogate downstream metabolic signaling. Exposure to the peptide can reduce cellular glucose output in hepatoma cells under glucagon challenge or modulate insulin secretion in β‑cell lines, effects that are measured through biochemical assays of glucose concentration, glycogen content, or insulin ELISA. Accompanying mechanistic studies frequently assay second messenger systems:
- cAMP modulation: Amylin receptors couple to Gs proteins; thus, Cagrilintide can stimulate or inhibit adenylyl cyclase activity depending on the cellular context, measured by FRET‑based cAMP sensors.
- MAPK/ERK phosphorylation: Western blotting for phosphorylated ERK1/2 reveals the activation kinetics of mitogenic pathways, which may influence cell proliferation or survival in long‑term cultures.
Co‑incubation studies with other metabolically active peptides—such as glucagon‑like peptide‑1 (GLP‑1) analogues or insulin—permit exploration of additive or synergistic effects on lipid oxidation and glucose uptake, providing insight into the network of hormonal regulation that controls energy homeostasis.
Sourcing and Quality Assurance for Bulk Powder
Obtaining Cagrilintide bulk powder from a qualified supplier begins with evaluating the synthesis and quality‑control infrastructure. Reputable manufacturers employ solid‑phase peptide synthesis (SPPS) under Good Manufacturing Practice (GMP) conditions, with controlled room temperature and humidity to minimize side reactions. The crude peptide is purified by preparative HPLC to >95% purity, and the final product is lyophilized in an ISO‑classified cleanroom. Customers typically request a pre‑shipment sample for independent verification, and full analytical dossiers are made available upon mutual agreement.
Certificates of Analysis (CoA) accompany every lot, listing HPLC purity, net peptide content, mass spectrometry data, and residual solvent levels. These documents enable downstream users to meet their own institutional quality standards and to maintain traceability in publications. For projects requiring even higher purity (>98%) or specific salt forms (e.g., acetate instead of trifluoroacetate), custom processing can often be arranged through the supplier’s technical team.
Packaging and Documentation
Cagrilintide bulk powder is typically packaged in multiples of 100 mg or 1 g per glass vial, sealed under argon with fluoropolymer‑coated stoppers. Larger quantities are supplied upon request, with each container labeled with the product name, lot number, net weight, and expiry date. Alongside the material, the following documentation is provided:
- Material Safety Data Sheet (MSDS): outlines handling precautions, personal protective equipment recommendations, and spill‑cleanup procedures.
- Handling and Reconstitution Guide: a technical bulletin summarizing solubility, recommended solvents, and storage guidelines for the specific lot.
Lot‑level traceability is maintained from raw amino acid resins through to the final vial, allowing researchers to correlate experimental outcomes with a defined production history—a critical requirement for peer‑reviewed publication and regulatory submissions.
Regulatory Compliance for Research Use
All Cagrilintide bulk powder offered by our organization is classified exclusively as a laboratory reagent. It is not manufactured under pharmaceutical drug regulations (e.g., 21 CFR Part 211), nor is it intended for introduction into humans or animals. International shipments comply with chemical control regulations, including those enforced by the U.S. Drug Enforcement Administration (DEA) and the European Chemicals Agency (ECHA), where applicable. A statement confirming the research‑only purpose is affixed to each outer package and referenced on the commercial invoice.
For export, a customs‑ready invoice with harmonized system (HS) code appropriate for peptides is supplied, along with a certificate of origin if required. Researchers at public institutions and commercial distributors alike benefit from this documentation, which streamlines clearance and ensures compliance with institutional biosafety and import policies.
Conclusion
Cagrilintide bulk powder represents a versatile, high‑purity reagent for advanced peptide biology research. From receptor‑binding kinetics and molecular pharmacology to metabolic pathway dissection in cell‑based systems, the lyophilized powder provides a consistent and well‑characterized starting material. Analytical rigor—routinely surpassing 95% purity—together with thorough identity verification by mass spectrometry and amino acid analysis, delivers the reproducibility that modern laboratories demand.
Our organization stands ready to support your research with competitive bulk pricing, custom synthesis options, and detailed technical data packages. Whether you are an academic core facility planning long‑term receptor studies or a distributor seeking a reliable source of premium‑grade peptides, we invite you to discuss your requirements with our scientific sales team. Inquiries regarding gram‑scale lots, specific salt forms, or third‑party analytical transfers are welcome and will be addressed with the confidentiality and speed appropriate for your project timelines.
Research‑use‑only notice: This product is supplied solely for in vitro laboratory experimentation. It is not intended for use in the diagnosis, mitigation, treatment, or prevention of any disease, nor for administration to humans or animals. Any application outside of controlled benchtop research is strictly prohibited and may violate applicable laws. All customers must confirm their status as qualified research professionals before order acceptance.
Réservé à la recherche. Ne pas utiliser chez l'homme ni chez les animaux.
